{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:08:16Z","timestamp":1792519696431,"version":"4.5.0"},"reference-count":25,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To compare the clinical characteristics and prognosis of primary conjunctival versus other ocular adnexal extranodal marginal zone B-cell lymphoma (EMZL).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective review of clinical records for all consecutive patients with primary ocular adnexal EMZL treated from March 1995 to December 2015.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>198 patients were evaluated including 81 with primary conjunctival and 117 with other ocular adnexal EMZL. Conjunctival EMZL was found at a younger age (40.3\u00b110.3vs 54.3\u00b113.4 years, p&lt;0.0001) with a female predilection (75.3%vs35.9%, p&lt;0.0001) and had a higher rate of bilaterality (40.7%vs11.1%, p&lt;0.0001) and a lower rate of systemic involvement (1.2%vs9.4%, p=0.030) compared with other ocular adnexal EMZLs. Conjunctival EMZL also showed a higher rate of complete response to primary treatment (98.8%vs89.5%, p=0.016) than other ocular adnexal EMZLs; however, recurrence and lymphoma-related death rates were not different between the two groups (p&gt;0.05). Kaplan-Meier estimates for disease-specific survival at 5 and 10 years were 98.2% and 98.2% in conjunctival and 98.6%, respectively, and 95.2% in other ocular adnexal EMZLs. Univariate analysis showed that systemic involvement was negatively associated with conjunctival tumour location and positively associated with age (OR=0.35\u2009and OR=1.05, p=0.045\u2009and p=0.012, respectively), and treatment response was positively associated with conjunctival tumour location and negatively associated with age (OR=3.02\u2009and OR=0.95, p=0.035\u2009and p=0.009, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Conjunctival EMZL shows unique demographic characteristic compared with other ocular adnexal EMZLs. Long-term follow-up is required due to late recurrence in ocular adnexal EMZL.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-310741","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T01:00:26Z","timestamp":1502931626000},"page":"502-508","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa"],"prefix":"10.1136","volume":"102","author":[{"given":"Seung Wan","family":"Nam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung In","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Duck","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,8,16]]},"reference":[{"key":"2020050713005693000_102.4.502.1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21963"},{"key":"2020050713005693000_102.4.502.2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.6.742"},{"key":"2020050713005693000_102.4.502.3","doi-asserted-by":"crossref","unstructured":"Amin MB , Edge S , Greene F , et al . AJCC cancer staging manual. 8th edn. New York, NY: Springer, 2017.","DOI":"10.1007\/978-3-319-40618-3_2"},{"key":"2020050713005693000_102.4.502.4","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.12.1668"},{"key":"2020050713005693000_102.4.502.5","doi-asserted-by":"crossref","unstructured":"Yoon JS , Ma KT , Kim SJ , et al . Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions. Ophthal Plast Reconstr Surg 2007;2 doi:10.1097\/IOP.0b013e318030b058","DOI":"10.1097\/IOP.0b013e318030b058"},{"key":"2020050713005693000_102.4.502.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050"},{"key":"2020050713005693000_102.4.502.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"2020050713005693000_102.4.502.8","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.85.1.63"},{"key":"2020050713005693000_102.4.502.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-714584"},{"key":"2020050713005693000_102.4.502.10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.survophthal.2015.05.001","article-title":"Malignant lymphoma of the conjunctiva","volume":"60","author":"Kirkegaard","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"2020050713005693000_102.4.502.11","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880366"},{"key":"2020050713005693000_102.4.502.12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11539"},{"key":"2020050713005693000_102.4.502.13","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.12.1663"},{"key":"2020050713005693000_102.4.502.14","doi-asserted-by":"crossref","unstructured":"Thuro BA , Ning J , Peng SA , et al . Rates of positive findings on positron emission tomography and bone marrow biopsy in patients with ocular adnexal lymphoma. Ophthal Plast Reconstr Surg 2016:1.doi:10.1097\/IOP.0000000000000789","DOI":"10.1097\/IOP.0000000000000789"},{"key":"2020050713005693000_102.4.502.15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2141.2010.08429.x","article-title":"Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients","volume":"152","author":"Bayraktar","year":"2011","journal-title":"Br J Haematol"},{"key":"2020050713005693000_102.4.502.16","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3109\/10428194.2013.826353","article-title":"Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphoma","volume":"55","author":"Nasser","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"2020050713005693000_102.4.502.17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1244"},{"key":"2020050713005693000_102.4.502.18","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.3109\/10428194.2015.1030640","article-title":"18F-Fluorodeoxyglucose (FDG)-positron emission tomography\/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement","volume":"56","author":"Park","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"2020050713005693000_102.4.502.19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.22608\/APO.2016209","article-title":"Lymphoproliferative Tumors of the Ocular Adnexa","volume":"6","author":"Verdijk","year":"2017","journal-title":"Asia Pac J Ophthalmol"},{"key":"2020050713005693000_102.4.502.20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh102"},{"key":"2020050713005693000_102.4.502.21","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.132316"},{"key":"2020050713005693000_102.4.502.22","doi-asserted-by":"publisher","DOI":"10.1080\/02841860701630283"},{"key":"2020050713005693000_102.4.502.23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamaophthalmol.2015.6122","article-title":"Conjunctival Lymphoma--An International Multicenter Retrospective Study","volume":"134","author":"Kirkegaard","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2020050713005693000_102.4.502.24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"Thieblemont","year":"2000","journal-title":"Blood"},{"key":"2020050713005693000_102.4.502.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)00767-3"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-310741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T08:32:11Z","timestamp":1659342731000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-310741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,16]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,3,23]]},"published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1136\/bjophthalmol-2017-310741"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310741","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,16]]}}}